# BlueLinx Holdings Inc. (BXC)

> Source: Nexqual · https://nexqual.com/BXC · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, BlueLinx Holdings Inc. (BXC), nexqual.com/BXC" · informational, not investment advice.

**Price:** USD 80.35 (+6.30% on the day) · last close of Oct 22, 2026; US market pre market, not a live price. Prev close 75.59 · day 76.2–80.45 · 52w 44.78–93.8 · market cap $632M · NYQ

## Key facts
- Last four reported quarters (through Jul 4, 2026): revenue $3.01B, net income -$1.9M (-0.1% margin), free cash flow $58.0M (SEC filings).
- 1 of 80 tracked superinvestors hold BXC (13F, Q2 2026): 0 new, 0 added, 0 reduced, 1 unchanged.
- Insider open-market sales, last ~7 months: 1 Form 4 filings, $2.9M; 1 not under a Rule 10b5-1 plan ($2.9M); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Hold (mean 2.50 on a 1–5 scale) (4 analysts), mean target USD 88.33 (range 83–98).
- Total return with dividends: 1Y +12.1% vs S&P 500 +14.9%; 5Y +62.8% vs S&P 500 +80.3%.
- Next earnings: 2026-11-03, EPS estimate USD 0.6, revenue estimate $814M.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $4.28B | $4.45B | $3.14B | $2.95B | $2.95B | $3.01B |
| Gross profit | $778M | $833M | $527M | $489M | $452M | — |
| Operating income | $438M | $439M | $138M | $87.6M | $32.5M | $34.7M |
| Net income | $296M | $296M | $48.5M | $53.1M | $219K | -$1.9M |
| EPS (diluted) | $29.99 | $31.51 | $5.39 | $6.19 | $0.02 | — |
| Free cash flow | $131M | $364M | $279M | $45.1M | $32.9M | $58.0M |
| Gross margin | 18.2% | 18.7% | 16.8% | 16.6% | 15.3% | — |
| Operating margin | 10.2% | 9.9% | 4.4% | 3.0% | 1.1% | 1.2% |
| Net margin | 6.9% | 6.7% | 1.5% | 1.8% | 0.0% | -0.1% |
| Revenue growth | +38.1% | +4.0% | -29.5% | -5.9% | +0.0% | — |
| Cash + short-term investments | $85.2M | $299M | $522M | $506M | $386M | — |
| Total debt | $566M | $565M | $294M | $295M | $297M | — |
Fiscal years end Jan. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jul 4, 2026)
P/S 0.2x · EV/EBITDA 7.8x · EV/Sales 0.2x · P/FCF 10.9x · P/B 1.0x · FCF yield 9.19% · Earnings yield -0.31% · Buyback yield (TTM) 1.28% · Net cash $21.1M · EV $610M
P/E at fiscal year-ends: Jan 2026 2553.4x, Dec 2024 16.5x, Dec 2023 21.0x.

## Superinvestors (SEC 13F-HR, Q2 2026)
1 of 80 tracked investors hold BXC. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Third Avenue Management |  | 0.64% | $4.0M | Unchanged |

## Insider sales (SEC Form 4, open-market, last ~7 months)
0 of 1 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-08-06 | Fennebresque Kim S | Director | 34,138 | $2.9M | 72.4% | No | Too little history (no open-market trades in 2023–2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.

## Analysts
Consensus Hold (mean 2.50 on a 1–5 scale), 4 analysts; mean target USD 88.33 (low 83, high 98).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-24 | Citizens | Initiated | Market Perform |  |
| 2026-08-06 | DA Davidson | Target raised | Neutral | $65 → $84 |
| 2026-08-06 | Benchmark | Target raised | Buy | $75 → $83 |
| 2026-07-15 | DA Davidson | Maintained | Neutral | $65 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-18) |
|---|---|---|
| Total return | +12.1% | +62.8% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +12.1% | +10.2% |
| Volatility (annualized) | 65.1% | 59.4% |
| Max drawdown | -42.6% (Feb 2026→Mar 2026) | -65.2% (Mar 2024→Mar 2026) |

## Peers (Industrial Distribution)
TITN (Titan Machinery Inc.) USD 22.99 +0.44% · DSGR (Distribution Solutions Group, I) USD 35.07 +0.06% · GIC (Global Industrial Company) USD 44.91 +0.07% · DXPE (DXP Enterprises, Inc.) USD 157.66 -11.20% · REZI (Resideo Technologies, Inc.) USD 17.79 +1.77% · DNOW (DNOW Inc.) USD 15.41 -4.29%

## More
Full page: https://nexqual.com/BXC · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Revenue by product line (quarter ended 2026-07-04)

| Line | Revenue | Share | YoY |
|---|---|---|---|
| Specialty products | $564.1M | 69.3% | +3.8% |
| Structural products | $249.9M | 30.7% | +5.6% |
| Total revenue | $814.1M | 100% | — |

## Company outlook (8-K filed 2026-08-04)

- "THIRD QUARTER 2026 OUTLOOK We are expecting specialty product gross margin to be in the range of 18.0% to 19.0%, and structural product gross margin to be in the range of 8.5% to 9.5%."
- "We also expect average daily sales volumes to be higher compared to the third quarter of fiscal 2025, and improve slightly sequentially from second quarter 2026."

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $0.60 | $0.34 | +74.9% | $814.2M | 3 |
| Next quarter (ends 2026-12-31) | $-0.08 | $-0.04 | +77.8% | $758.8M | 3 |
| Current fiscal year (ends 2026-12-31) | $1.89 | $0.91 | +108.5% | $3.12B | 3 |
| Next fiscal year (ends 2027-12-31) | $2.85 | $2.31 | +23.5% | $3.26B | 3 |